Active substances
Calcium carbonate + Sodium alginate + Sodium bicarbonate
- SFDA 8
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| GAVISCON DOUBLE ACTION CHEWABLE TABLET | 250,187.5,106.5 mg,mg,mg | Chewable tablet · Oral use | 32 Blister | SAR 21.10 | NCE · OTC | RECKITT BENCKISER HEALTHCARE INTERNATIONAL | Valid |
| GAVISCON DOUBLE ACTION CHEWABLE TABLET | 250,187.5,106.5 mg,mg,mg | Chewable tablet · Oral use | 16 Blister | SAR 10.55 | NCE · OTC | RECKITT BENCKISER HEALTHCARE INTERNATIONAL | Valid |
| GAVISCON DOUBLE ACTION ORAL SUSPENSION | 500,325,213 mg,mg,mg | Oral suspension · Oral use | 1 Bottle | SAR 25.10 | Generic · OTC | RECKITT BENCKISER HEALTHCARE INTERNATIONAL | Valid |
| GAVISCON DOUBLE ACTION ORAL SUSPENSION | 500,325,213 mg,mg,mg | Oral suspension · Oral use | 1 Bottle | SAR 12.55 | Generic · OTC | RECKITT BENCKISER HEALTHCARE INTERNATIONAL | Valid |
| GAVISCON ORIGINAL ANISEED ORAL SUSP | 500,267,160 mg,mg,mg | Oral suspension · Oral use | 1 Bottle | SAR 15.20 | Generic · OTC | RECKITT BENCKISER | Valid |
| GAVISCON PEPPERMINT CHEWABLE TABLETS | 250,133.50,80 mg,mg,mg | Chewable tablet · Oral use | 16 Blister | SAR 9.60 | Generic · OTC | RECKITT BENCKISER | Valid |
| GAVISCON PEPPERMINT LIQUID | 500,267,160 mg,mg,mg | Oral suspension · Oral use | 1 Bottle | SAR 15.20 | Generic · OTC | RECKITT BENCKISER | Valid |
| GAVISCON COOL CHEWABLE TABLETS | 250,133.5,80 mg,mg,mg | Chewable tablet · Oral use | 16 Blister | SAR 8.00 | Generic · OTC | RECKITT BENCKISER HEALTHCARE COMPANY | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
ANESTHESIA-SUPPORTIVE AGENTS/ ASPIRATION PNEUMONIA PROPHYLAXIS; GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.